Use necessary cookies only Necessary Preferences Statistics Marketing Show details Ferrer Health professionals join us News IT IS Main Navigation We are Ferrer Great people Liveable Planet Social justice Our activity Contact News Ferrer begins phase III clinical trial, ADORE, of FNP122 in amyotrophic lateral sclerosis (ALS) SEE MORE Previous Next # section-two We are Ferrer We generate a positive impact on society / en / we-ferrer / ferrer-for-good # section-three Great people We promote a people-centered culture / en / great-people # section-four Liveable Planet We promote the protection of the environment / en / liveable-planet # section-five Social justice We support people in vulnerable situations / en / social-justice # section-six Our activity What allows us to commit to initiatives that have a positive impact on society / en / our-activity / specialization # section-seven Do you have any question? Contact us. If you want to make a consultation, request medical information, become our partner, request an interview, report an adverse reaction or make a quality claim, leave us a message CONTACT US Connect with us Contact join us News Social networks footer Facebook linkedin Youtube Instagram Twitter European Union - European Regional Development Fund (ERDF) Legal footer Legal warning Privacy Policy Cookies policy © 2020 Copyright Grupo Ferrer Internacional, SA All rights reserved